AnaptysBio Announces Appointment of J. Anthony Ware, M.D. to Board of Directors
Aug 24, 2017 12:00 pm UTC| Business
SAN DIEGO, Aug. 24, 2017 -- AnaptysBio, Inc. (Nasdaq:ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced...
NEW REPORT FROM GRANTMAKERS IN AGING EXPLORES IMPACT OF THE OPIOID EPIDEMIC ON RURAL AGING
Aug 24, 2017 12:00 pm UTC| Business
Washington, DC, Aug. 24, 2017 -- The opioid crisis is a story of many types of pain, and how individuals, families, and entire communities – particularly small and rural ones – are becoming collateral damage. A new...
Aug 24, 2017 12:00 pm UTC| Business
SAN FRANCISCO, Aug. 24, 2017 -- FinancialForce, the leading Cloud ERP for the new services economy, today announced the appointment of Gordy Brooks as Chief Financial Officer. Brooks, former Citrix GetGo and Aerohive...
Global Self Storage to Present at the 6th Annual Liolios Gateway Conference on September 7, 2017
Aug 24, 2017 12:00 pm UTC| Business
NEW YORK, Aug. 24, 2017 -- Global Self Storage, Inc. (NASDAQ:SELF), a real estate investment trust (“REIT”) that owns and operates self storage facilities, has been invited to present at the 6th Annual Liolios Gateway...
Haven and JAGGAER Partner to Provide Unmatched Efficiency for Supply Chain Professionals
Aug 24, 2017 12:00 pm UTC| Business
RESEARCH TRIANGLE PARK, N.C., Aug. 24, 2017 -- JAGGAER, producers of the world’s most comprehensive Source to Pay (S2P) solutions suite, today announced a global alliance with Haven, a San Francisco based transportation...
R1 RCM to Present at Two Upcoming Investor Conferences
Aug 24, 2017 12:00 pm UTC| Business
CHICAGO, Aug. 24, 2017 -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of revenue cycle management and physician advisory services to healthcare providers, today announced its management team will present at two...
Aug 24, 2017 12:00 pm UTC| Business
BROOKLYN, N.Y., Aug. 24, 2017 -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases,...